Why the study?
Should patients with cardiovascular disease be screened for chronic kidney disease using the MDRD equation and microalbuminuria testing?
Should patients with cardiovascular disease be screened for chronic kidney disease using the MDRD equation and microalbuminuria testing?
This advisory recommends that all patients with cardiovascular disease be screened for chronic kidney disease using the MDRD equation and microalbuminuria testing.
Supports screening all CVD patients for CKD; confirms reliable detection with MDRD equation plus microalbuminuria testing.
Chronic kidney disease (CKD) occurs commonly in patients with cardiovascular disease. In addition, CKD is a risk factor for the development and progression of cardiovascular disease. In this advisory, we present recommendations for the detection of CKD in patients with cardiovascular disease. CKD can be reliably detected with the combined use of the Modification of Diet in Renal Disease equation to estimate glomerular filtration rate and a sensitive test to detect microalbuminuria. All patients with cardiovascular disease should be screened for evidence of kidney disease with these two determinations.
No takes yet. Share an insight, caveat, or question.
Brosius et al. (2006) conducted a review in Chronic kidney disease in patients with cardiovascular disease. Screening for chronic kidney disease (MDRD equation and microalbuminuria test) was evaluated. Screening for chronic kidney disease in all patients with cardiovascular disease is recommended using the Modification of Diet in Renal Disease equation and a sensitive test for microalbuminuria.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: